Umargarr:


We are here seazing the opportunity to load more...e dey vex you?

baba calm down
We dey wait for am at less than 6km

Mcy56:
Access: 8.05
UBA: 7.90

If I were to buy, I will pick Access ahead of UBA.
Abeg make Una no mind me o, both are good..........not any form of advice.......DD applies.

Now UBA leading at 8:20....looks like both are husband and wife but I agree with access first if not for anything for dividends gain. The interim from UBA was lower than access

Brent Crude oil $46.56

Discovery of Coro-Vaccine and election of Bidden doing crude oil price and global economy a lot of good.

On Monday we were asking people to buy...

Today we will just siddon dey look as people scramble to buy very decent stocks at rock bottom prices...

Always buy the red candles and sell the green candles

Good luck to you all

Mcy56:

Oga Selly, who is stage managing today's green again ?
Or the recession has ended just today?

I COULD be wrong Mcy. nothing is cast in stone

Mcy56:

Oga Selly, who is stage managing today's green again ?
Or the recession has ended just today?

RealityShot:
thank you for that.

Ask him also,
So because of negative rates in MMF, I will go and buy GTB at N37 or more baa?

(when their last final dividend is N2.50k which will give me a poor 6% profit mtchewww)

Senior men have finally said the truth about my question on GTB.

The guy that bought UBA yesterday at N7.50 must be smiling now.

PharmAlfred:
The guy that bought UBA yesterday at N7.50 must be smiling now.

I gave him hope last night.

Is this the oando I bought at 2.75-79 this morning?

Who said Jijo no sweet.........

Hello, I would like to learn how this work. What do I need to start trading and I want to also if the app cahaka on playstore is good for beginners.

And please I would love if I can get resources from here.

locodemy:


I gave him hope last night.

Very necessary. There was no reason for the panic we saw yesterday. We have been in recession for as a long as we can remember. Nothing has changed in market. Companies are still making profit.

This market good now than that hurricane bull that reduced my paper profit to half before I could sell off.
At least you can now cast net and draw out some fishes.

PharmAlfred:


Very necessary. There was no reason for the panic we saw yesterday. We have been in recession for as a long as we can remember. Nothing has changed in market. Companies are still making profit.

Prophets and messengers of doom seems to have gone into hiding

.......

Even Transcorp wan catch meat too.

locodemy:
Even Transcorp wan catch meat too.

Went as low as 82kobo earlier..................now at 91kobo.
My ogas talk say na scam................
We don refrain from talking about it.............and other "covid-induced stocks" as dem talk say na monkey biz.

Fidelity : Just vexing anyhow....................up with 22kobo as at now! ..............24kobo............

Late to the party today, just confuse on what to buy now.....

Mcy56:
Fidelity : Just vexing anyhow....................up with 22kobo as at now! ..............24kobo............

Correct meat for Loco

Treasury bill maturity Thursday, more money entering the market

Neimeth meat done half today.
Tomorrow e go done.

MPC meeting briefing ongoing by CBN governor. Retains MPR at 11.5%. Also retains all other key parameters.
Desires continued growth in the economy in order to exit the recession quickly. Also acknowledges and desire continued growth in equities in the NSE among other things.

This is my own small summary o. Nobody should quote me.

Please how can one generate a growth rate to be used in analysing a stock?
Is it a constant value for a sector?

Good Afternoon, please which stocks can l buy tomorrow? I have GSK in mind. Thanks

Sexybeautiful:
Good Afternoon, please which stocks can l buy tomorrow? I have GSK in mind. Thanks

You didn't buy it yesterday.
Today,it gave room for new entrants.
Market is now on timing.
You will have your village people to blame if you don't time.

Making money in stock market is a marathon and not an event.

If you are patient enough, you will definitely make a lot of money from the market

samguru:
Making money in stock market is a marathon and not an event.

If you are patient enough enough, you will definitely make lot of money from the market

Examples Sir

Us market recovery is the cause of what we are witnessing in our own market now.Follow the Us market to make a kill at NSE.


This year has been a true rollercoaster ride for the U.S. oil and gas market, but it is increasingly looking to end on a high note.

The sector is up nearly 16% over the past 10 days alone as the world moves closer to vanquishing one of mankind's biggest threats in modern history.

The outlook keeps getting better for the oil and gas bulls.

Here are three key reasons why the bulls are likely to have the upper hand going forward.

#1. Covid-19 vaccines

The oil and gas industry has been deeply out of favor over the past few years, thanks to huge supply/demand imbalances that only got much worse after Covid-19 struck. Indeed, trying to call a bottom on the bear market has largely been a fool's errand as one step forward (OPEC production cuts) was immediately met by several steps backward (massive demand destruction due to global lockdowns).

However, the latest developments now offer hope to the incurable optimists that the worst might finally be in the rearview mirror for the industry.

At least two successful COVID-19 vaccines now mark a major turning point in the battle against one of our biggest existential crises.

Two weeks ago, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) reported that their joint mRNA-based COVID-19 vaccine candidate, BNT162b2, had demonstrated nearly 95% efficacy in preventing Covid-19 infections in ~44,000 test patients. A few days ago, the companies confirmed those numbers in their final analysis, including being 94% effective in those over 65 years old.

Related: Venezuela Arrests Oil Workers To Cover Up Bad Press About PDVSA

The good news came with a small caveat though: Pfizer's vaccine needs a much cooler temperature of -94 degrees Fahrenheit (-70° C) and up to -109 degrees Fahrenheit for shipment for the vaccine to remain viable, which could pose a major challenge in some locations.

So news that Moderna's (NASDAQ:MRNA) Covid-19 vaccine candidate, mRNA-1273, has demonstrated similar efficacy as the Pfizer vaccine but remains stable at more manageable temperatures of 2° to 8°C (36° to 46°F), or roughly the same operating temperature of a standard home or medical refrigerator, for at least a month, was definitely great news.

More encouraging: Moderna has reported that its Covid-19 vaccine will cost $25 and $37 per dose depending on the amount ordered, roughly in the ballpark of a common flu shot, which costs anywhere from $10 to $50.

Even more encouraging news: The EU is likely to fast track approval for the Pfizer and Moderna vaccines, meaning they could enter mainstream distribution in its jurisdiction in a matter of weeks. Europe is experiencing the biggest second Covid-19 wave, with Germany, Poland, France, and Spain having gone back to lockdown in a bid to stem the spread of the deadly virus.

#2. More vaccines in the pipeline

Other than his never-ending tweetstorm, Trump has mainly kept a low public profile after losing to Biden in one of America's most divisive elections in modern history. But a few days ago, he came out and publicly accused Pfizer of delaying its Covid-19 vaccine ostensibly in a bid to ruin his chances at re-election.

Well, guess what, it appears several other pharmaceutical companies are guilty of the same curious timing of their own--maybe even better--vaccines.

Related: Why Iraq Isn’t Producing 10 Million Barrels Per Day Yet

The Pfizer and Moderna vaccines are based on Messenger RNA technology, which is not only speedier to manufacture and develop but is also well-suited to rapid adaptation.

Unfortunately, messenger RNA, or mRNA, is also delicate, requiring careful cold storage and handling that complicate distributions.

The great news: There are several other vaccines that could be better suited for more widespread distribution.

AstraZeneca (NASDAQ:AZN) and the University of Oxford have reported that their vaccine is 62-90% effective depending on dosage, but is cheaper than the Pfizer or Moderna vaccine and can also be stored at higher temperatures making it more accessible for lower-income nations. The AstraZeneca candidate is an adenovirus-vector platform that gives people an inactivated virus to stimulate an immune response making it more stable than Pfizer and Moderna's "mRNA-based" vaccines.

CureVac's (NASDAQ:CVAC) says its CVnCoV vaccine is stable for three months at +5 Celsius or the standard refrigerator temperature. The vaccine remains stable for up to ready-to-use room temperature for 24 hours.

Sanofi and GlaxoSmithKline's have announced that their two-dose recombinant protein vaccine can be stored between 2°C- 8°C.

Johnson & Johnson also has a Covid-19 vaccine in the pipeline, which, if successful, could be stable at refrigerated temperatures of 2°C - 8°C for at least three months and up to two years at -20 °C.

In short, there seems to be no shortage of Covid-19 vaccine candidates that are potentially even more stable than the Pfizer/BioNTech vaccine.

#3. Undervalued sector

The U.S. and global energy sectors have been deeply out of favor for the past six years--so much so that the sector could now be significantly undervalued.

In fact, the sector now trades at a price-to-book ratio below one, the lowest in about seven decades.

That would not mean much in the face of the huge supply/demand imbalances that rocked the industry at the beginning of the year. But the situation is quite different now.

Over the past few months, OPEC has demonstrated admirable production discipline and will be looking to maintain that trajectory to avoid derailing the oil price recovery.

The long-term oil price outlook might not be too dire, either.

The age of renewables might be upon us, yet oil demand could keep growing and only hit a plateau in the late 2030s as per OPEC estimates. Granted, those rosy projections might quickly turn gloomy if many more governments go the U.K. route and decide to ban petrol and diesel vehicles on their roads by the turn of the decade. But so far, indications are that the fossil fuel sector might have at least several more years of dominance as long as the global pandemic can be quickly brought under control--and the prognosis is quite good.

locodemy:


You didn't buy it yesterday.
Today,it gave room for new entrants.
Market is now on timing.
You will have your village people to blame if you don't time.

Some stocks have not left where they were since yesterday's massive crash, like Zenith, GT, Ibtc, Fidelity, ETI, Access, Dangsugar, Wapco and so on.